Axogen Inc vs Lucid Group Inc — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Lucid Group Inc trades at $4.61 (market cap $1.80B). The key difference: Axogen Inc and Lucid Group Inc are close in size by market cap, and Axogen Inc is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | LCID | |
|---|---|---|
Market Cap | $2.06B | $1.80B |
Sector | Technology | Consumer Cyclical |
52-Week High | $46.19 | $31.30 |
52-Week Low | $11.28 | $4.62 |
Enterprise Value | $1.98B | $4.27B |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Lucid Group (LCID) trades at $5.51, down 0.72% amid significant volatility following bankruptcy rumors that the company denied on July 14, 2026. The stock shows bearish technical signals with negative financial metrics including a -239.81% net income margin and consistent earnings misses. Recent news highlights restructuring advisory engagement and multiple class-action lawsuits filed against the company, creating substantial investor uncertainty.
The outlook remains highly speculative with severe fundamental challenges including massive losses, negative cash flow, and declining revenue. While analyst consensus targets $10.50, representing 91% upside, the overwhelming hold/sell ratings and ongoing legal pressures suggest significant downside risk. Investment requires high risk tolerance given the company's financial distress and competitive EV market pressures.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →